Clinical Trial Supply Chain Logistics Discussed At Upcoming Flypharma Conference
Somerset, N.J. – August 27, 2015 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Ms. Esther Sadler-Williams, Global Director Strategic Development and Innovation, will present at the upcoming FlyPharma Conference, to be held at the Radisson Blu Edwardian Hotel, London Heathrow, on September 9th – 10th, 2015.
Ms. Sadler Williams’ presentation, on Wednesday, September 9th, at 11.30 a.m., is entitled “Clinical Trial Logistics: A Different Perspective on the Supply Chain” and will discuss the complexities and challenges to ensure that the right product gets to the right patient, at the right time. An overview of a typical supply chain will be presented, providing background to the reasons for some of the idiosyncrasies needed to support the clinical research processes. As well as a case study, potential future strategies will also be discussed.
Ms. Sadler-Williams M.Sc., MRPharmS. is the past EU chair of the ISPE Investigational Products Codes of Practice. As a pharmacist, she has had nearly 30 years’ experience in various pharmaceutical fields, latterly in clinical supply environments, but she also worked for five years with Sanofi Winthrop, where she was Head of Research Services managing groups of CRAs, medical writers and information/adverse event surveillance specialists. Her previous roles include Principal Pharmacist with the Regional Drug Information Service at St Mary’s Hospital in Manchester, UK, and Pharmacy Manager with Boots the Chemist.
For more information on the FlyPharma Conference, visit: www.flypharmaconference.com and to arrange a meeting with Ms. Sadler-Williams, contact Richard Kerns at NEPR- richard@nepr.eu.
About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,700 people, including over 1,000 scientists, at 30 facilities across 5 continents, and in fiscal 2014 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit www.catalent.com